Arkema Mole Sieve - MSDS - July 2018

SAFETY DATA SHEET
SILIPORITE®
1. PRODUCT AND COMPANY IDENTIFICATION
Company
Arkema Inc.
900 First Avenue
King of Prussia, Pennsylvania 19406
Ceca
Customer Service Telephone Number: 1-800-248-2322

(Monday through Friday, 8:00 AM to 5:00 PM EST)
Emergency Information
Transportation: CHEMTREC: (800) 424-9300

(24 hrs., 7 days a week)
Medical: Rocky Mountain Poison Center: (866) 767-5089
(24 hrs., 7 days a week)
Product Information
Product name: SILIPORITE®

Synonyms: Molecular Sieves, Bead/Extrudate, See section 16 for Bead and
Extrudate Grades
Molecular formula: Mixture
Chemical family: Synthetic Zeolites
Product use: Absorbent
2. HAZARDS IDENTIFICATION
Emergency Overview
Color: off-white
Physical state: solid
Form: Beads or extrudates of different sizes.
Odor: None.
*Classification of the substance or mixture:

Carcinogenicity, Category 1A, H350
Specific target organ toxicity - repeated exposure, Category 1, H372
*For the full text of the H-Statements mentioned in this Section, see Section 16.
Product code: 43000 Version 2.10 Issued on: 03/27/2018 Page: 1 / 23
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
GHS-Labelling
Hazard pictograms:
Signal word: Danger
Hazard statements:
H350 : May cause cancer.
H372 : Causes damage to organs through prolonged or repeated exposure.
Supplemental Hazard Statements:

Specific target organ toxicity - repeated exposure:
lungs.
Precautionary statements:
Prevention:
P201 : Obtain special instructions before use.
P202 : Do not handle until all safety precautions have been read and understood.
P260 : Do not breathe gas/mist/vapours/spray.
P264 : Wash skin thoroughly after handling.
P270 : Do not eat, drink or smoke when using this product.
P281 : Use personal protective equipment as required.
Response:
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
Storage:
P405 : Store locked up.
Disposal:
P501 : Dispose of contents/ container to an approved waste disposal plant.
Supplemental information:
Potential Health Effects:

The product will react with water and release heat. Prolonged contact can cause burns to moist body tissues.
(severity of effects depends on extent of exposure) Contains crystalline silica (as quartz, crystobalite, tridymite,
or tripoli) which is listed as a cancer hazard if inhaled.
Can also cause: lung effects, coughing, wheezing, breathing difficulties.
Medical conditions aggravated by overexposure:
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Respiratory disease or diminished respiratory capacity.
Other:
Zeolite is a mineral, composed of silicates and oxides of various metals, which exhibits different properties from a
simple mixture of the component molecules. Representative Zeolite materials are less irritating and have lower
acute and chronic toxicity than the component molecules. The primary health hazard of this product is associated
with heat generated upon contact with water.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Chemical Name CAS-No. Wt/Wt GHS Classification**
Aluminum oxide (Al2O3) 1344-28-1 >= 10 - < 30 % Not classified
Potassium oxide (K2O) 12136-45-7 >= 10 - < 30 % H314, H318
Sodium oxide (Na2O) 1313-59-3 >= 10 - < 30 % H271, H314, H318
Calcium oxide (CaO) 1305-78-8 >= 10 - < 30 % H315, H318, H335
Magnesium aluminium silicate 12174-11-7 >= 5 - < 10 % Not classified
Bentonite 1302-78-9 >= 5 - < 10 % Not classified
Sepiolite (Mg4(OH)2(Si2O5)3.6H2O) 63800-37-3 >= 5 - < 10 % H373
Kaolin 1332-58-7 >= 5 - < 10 % Not classified
Silica 7631-86-9 >= 1 - < 5 % Not classified
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Quartz (SiO2) 14808-60-7 >= 1 - < 5 % H350, H372
Cristobalite (SiO2) 14464-46-1 >= 0.1 - <= 1 % H350, H372
**For the full text of the H-Statements mentioned in this Section, see Section 16.
4. FIRST AID MEASURES
4.1. Description of necessary first-aid measures:
Inhalation:
If inhaled, remove victim to fresh air.
Skin:
In case of contact, immediately flush skin with plenty of water. Remove material from clothing. Wash clothing before
reuse. Thoroughly clean shoes before reuse.
Eyes:
Immediately flush eye(s) with plenty of water.
Ingestion:
If swallowed, DO NOT induce vomiting. Get medical attention. Never give anything by mouth to an unconscious
person.
4.2. Most important symptoms/effects, acute and delayed:
For most important symptoms and effects (acute and delayed), see Section 2 (Hazard Statements and Supplemental
Information) and Section 11 (Toxicology Information) of this SDS.
4.3. Indication of immediate medical attention and special treatment needed, if necessary:
Unless otherwise noted in Notes to Physician, no specific treatment noted; treat symptomatically.
5. FIREFIGHTING MEASURES
Extinguishing media (suitable):

Use extinguishing measures to suit surroundings.
Protective equipment:
Fire fighters and others who may be exposed to products of combustion should wear full fire fighting turn out gear
(full Bunker Gear) and self-contained breathing apparatus (pressure demand / NIOSH approved or equivalent).
Fire fighting equipment should be thoroughly decontaminated after use.
Further firefighting advice:
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
This material is not flammable.
Fire and explosion hazards:

When burned, the following hazardous products of combustion can occur:
Carbon oxides
Hazardous organic compounds
6. ACCIDENTAL RELEASE MEASURES
Personal precautions, Emergency procedures, Methods and materials for containment/clean-up:

Prevent further leakage or spillage if you can do so without risk. Ventilate the area. Avoid dust formation and
dispersal of dust in the air. Sweep up and shovel into suitable properly labeled containers for prompt disposal.
Possible fall hazard – floor may become slippery from leakage/spillage of product. Sweep or scoop up using non-
sparking tools and place into suitable properly labeled containers for prompt disposal. The sweepings should be
wetted down with water. Avoid dispersal of spilled material and runoff and contact with soil, waterways, drains and
sewers. Consult a regulatory specialist to determine appropriate state or local reporting requirements, for assistance
in waste characterization and/or hazardous waste disposal and other requirements listed in pertinent environmental
permits.
Protective equipment:
Appropriate personal protective equipment is set forth in Section 8.
7. HANDLING AND STORAGE
Handling
General information on handling:

Avoid breathing dust.
Do not taste or swallow.
Do not get in eyes, on skin, or on clothing.
Use only with adequate ventilation.
Keep container tightly closed.
Wash thoroughly after handling.
Emptied container retains product residue.
Observe all labeled safeguards until container is cleaned, reconditioned or destroyed.
Storage
General information on storage conditions:

Keep container tightly closed in a dry and well-ventilated place. Store away from moisture and heat to maintain the
technical properties of the product. Material recommended for re-packaging: high density polyethylene (HDPE),
polypropylene (PP), polytetrafluoroethylene (PTFE), fiberboard with moisture barrier.
Storage incompatibility – General:

Store away from moisture to maintain the technical properties of the product.
Store separate from:
Water
Strong acids
Strong bases
hydrofluoric acid
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Airborne Exposure Guidelines:
Aluminum oxide (Al2O3) (1344-28-1)
US. ACGIH Threshold Limit Values
Form: Respirable fraction.

Time weighted average 1 mg/m3
US. OSHA Table Z-1 Limits for Air Contaminants (29 CFR 1910.1000)

PEL: 5 mg/m3
Form: Total dust

PEL: 15 mg/m3
Calcium oxide (CaO) (1305-78-8)
PEL: 5 mg/m3
Kaolin (1332-58-7)

Remarks: The value is for particulate matter containing no
asbestos and <1% crystalline silica.

PEL: 5 mg/m3
Form: Total dust

PEL: 15 mg/m3
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Silica (7631-86-9)
US. OSHA Table Z-3 (29 CFR 1910.1000)
Time weighted average 20millions of particles per cubic foot of air
Time weighted average 0.8 mg/m3
Remarks: The exposure limit is calculated from the

equation, 80/(%SiO2), using a value of 100%
SiO2. Lower values of % SiO2 will give higher
exposure limits.
Quartz (SiO2) (14808-60-7)

Form: Respirable.
Time weighted average 2.4millions of particles per cubic foot of air
equation, 250/(%SiO2+5), using a value of 100%
SiO2. Lower percentages of SiO2 will yield
higher exposure limits.
Form: Respirable.

equation, 10/(%SiO2+2), using a value of 100%
SiO2. Lower percentages of SiO2 will yield
higher exposure limits.
PEL: 0.05 mg/m3
Only those components with exposure limits are printed in this section. Limits with skin contact designation above have skin contact
effect. Air sampling alone is insufficient to accurately quantitate exposure. Measures to prevent significant cutaneous absorption
may be required. Limits with a sensitizer designation above mean that exposure to this material may cause allergic reactions.
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Engineering controls:
Investigate engineering techniques to reduce exposures below airborne exposure limits or to otherwise reduce
exposures. Provide ventilation if necessary to minimize exposures or to control exposure levels to below
airborne exposure limits (if applicable see above).If practical, use local mechanical exhaust ventilation at
sources of air contamination such as open process equipment.
Respiratory protection:
Avoid breathing dust. Where airborne exposure is likely or airborne exposure limits are exceeded (if applicable,
see above), use NIOSH approved respiratory protection equipment appropriate to the material and/or its
components. Full facepiece equipment is recommended and, if used, replaces need for face shield and/or
chemical goggles. Consult respirator manufacturer to determine appropriate type equipment for a given
application. Observe respirator use limitations specified by NIOSH or the manufacturer. For emergency and
other conditions where there may be a potential for significant exposure or where exposure limit may be
significantly exceeded, use an approved full face positive-pressure, self-contained breathing apparatus or
positive-pressure airline with auxiliary self-contained air supply. Respiratory protection programs must comply
with 29 CFR § 1910.134.
Skin protection:
Wear appropriate chemical resistant protective clothing and chemical resistant gloves to prevent skin contact.
Consult glove manufacturer to determine appropriate type glove material for given application. Rinse
immediately if skin is contaminated. Wash contaminated clothing and clean protective equipment before reuse.
Provide a safety shower at any location where skin contact can occur. Wash thoroughly after handling.
Eye protection:
Where eye contact may be likely, wear chemical goggles and have eye flushing equipment available.
9. PHYSICAL AND CHEMICAL PROPERTIES
Color: off-white
Physical state: solid
Form: Beads or extrudates of different sizes.
Odor: None.
Odor threshold: No data available
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Flash point Not applicable
Auto-ignition No data available.

temperature:
Lower flammable limit Not applicable

(LFL):
Upper flammable limit Not applicable

(UFL):
pH: 8 - 11
Density: 0.63 - 0.85 g/cm3
Specific Gravity (Relative No data available

density):
Boiling point/boiling No data available

range:
Melting point/range: No data available.
Freezing point: No data available
Evaporation rate: No data available
Solubility in water: insoluble
Viscosity, dynamic: No data available
Oil/water partition No data available.

coefficient:
Thermal decomposition: No data available
Flammability: See GHS Classification in Section 2
10. STABILITY AND REACTIVITY
Stability:
This material is chemically stable under normal and anticipated storage, handling and processing conditions.
Hazardous reactions:
None known.
Materials to avoid:
Water
hydrofluoric acid
Strong acids
Strong bases.
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Conditions / hazards to avoid:

Avoid dust formation. Store protected from moisture (to maintain the technical properties of the product)
Hazardous decomposition products:
Thermal decomposition giving flammable and toxic products :
Hazardous organic compounds

Carbon oxides
11. TOXICOLOGICAL INFORMATION
Data on this material and/or its components are summarized below.
Data for Aluminum oxide (Al2O3) (1344-28-1)
Acute toxicity
Oral:
Practically nontoxic. (rat) LD0 > 15,900 mg/kg.
Inhalation:
No deaths occurred. (rat) 4 h LC0 > 2.3 mg/l. (dust)
Skin Irritation:
Practically non-irritating. (rabbit) (24 h)
Eye Irritation:
Causes mild eye irritation. (rabbit)
Skin Sensitization:
Not a sensitizer. Intradermal injection. (guinea pig) No skin allergy was observed
Repeated dose toxicity

Chronic inhalation administration to rat / No adverse systemic effects reported. (fiber was tested)
Human experience
Inhalation:
Upper respiratory tract: wheezing, shortness of breath, non-disabling structural lung changes. Exposures
exceeded recommended occupational exposure limit. (based on reports of occupational exposure to workers)
Human experience
Skin contact:
Skin: Mechanical irritation.
Human experience
Eye contact:
Eyes: Dust contact with the eyes can lead to mechanical irritation.
Data for Calcium oxide (CaO) (1305-78-8)
Acute toxicity
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Oral:
No deaths occurred. (rat) LD0 > 2,000 mg/kg.
Specific target organ toxicity - single exposure:

May cause respiratory irritation.
Skin Irritation:
Not irritating. (rabbit) OECD Test Guideline 404
Eye Irritation:
Causes serious eye damage. (rabbit) OECD Test Guideline 405

Repeated oral administration to rat / No adverse systemic effects reported.
Carcinogenicity
Chronic oral administration to rat / No increase in tumor incidence was reported. (data for a similar
material)
Genotoxicity
Assessment in Vitro:
No genetic changes were observed in a laboratory test using: bacteria
Genotoxicity
Assessment in Vivo:
No genetic changes were observed in laboratory tests using: rats
Developmental toxicity
Exposure during pregnancy. Oral (rat and mouse) / No birth defects were observed.
Human experience
Inhalation:
Upper respiratory tract: Discomfort, coughing, irritation, perforation of the nasal septum. (extent of injury
depends on severity of exposure)
Human experience
Skin contact:
Irritation, burning of skin. Irritant but not a sensitizer.
Human experience
Eye contact:
Severe irritation.
Data for Magnesium aluminium silicate (12174-11-7)
Carcinogenicity
Repeated administration to Rat / affected organ(s): upper respiratory tract / signs: fibrosis, tumors /
(Epidemiological studies have not formally shown any causal relationships between the incidence of
cancer and exposure to the product)
Classified by the International Agency for Research on Cancer as: Group 3: Unclassifiable as to carcinogenicity
in humans.
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Genotoxicity
No genetic changes were observed in a laboratory test using: animal cells
Data for Bentonite (1302-78-9)
Acute toxicity
Oral:
Dermal:
No deaths occurred. (rabbit) LD0 > 2,000 mg/kg.
Inhalation:
Practically nontoxic. (rat) 1 h LC50 > 200 mg/l.
Skin Irritation:
Practically non-irritating. (rabbit) (Mechanical irritation.)
Eye Irritation:
Causes mild eye irritation. (rabbit) (Mechanical irritation.)

Intratracheal administration to rat / affected organ(s): upper respiratory tract / signs: inflammation,
irritation, changes in organ structure or function
Repeated dietary administration to mouse / affected organ(s): liver / signs: decreased growth rate,
structural organ changes
Genotoxicity
No genetic changes were observed in a laboratory test using: bacteria
Other information
May contain silica. Crystalline silica is listed as a cancer hazard if inhaled.
Human experience
Inhalation:
Lungs: A benign dust induced lung condition, without impairment of lung function.. Exposures exceeded
recommended occupational exposure limit.
Respiratory tract: coughing, bronchitis, pneumonia. Risk of infection of the lung after prolonged inhalation of
dust particles.
Data for Sepiolite (Mg4(OH)2(Si2O5)3.6H2O) (63800-37-3)

Repeated dietary administration to human / No adverse effects reported.
Repeated dietary administration to rabbit / No adverse effects reported.
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Repeated inhalation administration to rat / No adverse effects reported.

May cause damage to organs through prolonged or repeated exposure.
Carcinogenicity
Inhalation administration to rat / No increase in tumor incidence was reported. (short fiber length)
Repeated injection administration to rat / No increase in tumor incidence was reported. (short fiber
length)
Repeated injection administration to rat and mouse / Increased incidence of tumors was reported. (long
fiber length)
The carcinogenic response in animal studies for these mineral fibers differed depending on the length of the
fiber tested. Short fibers did not cause an increase in tumor incidence after inhalation or injection; long, thin
mineral fibers did cause increases in tumor incidence.
Classified by the International Agency for Research on Cancer as:Group 3: Unclassifiable as to carcinogenicity
in humans.
Genotoxicity
No genetic changes were observed in laboratory tests using: animal cells
Genotoxicity
Assessment in Vivo:
No genetic changes were observed in laboratory tests using: human subjects
Human experience
Inhalation:
Respiratory tract: decreased lung function. (based on reports of occupational exposure to workers) (repeated or
prolonged exposure)
Data for Kaolin (1332-58-7)
Acute toxicity
Oral:
Practically nontoxic. (rat) LD50 = > 5,000 mg/kg.
Dermal:
Inhalation:
Practically nontoxic. (rat) 1 h LC50 = 36 mg/l. (dust)
Skin Irritation:
Not irritating. (rabbit)
Eye Irritation:
Causes mild eye irritation. (rabbit)
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®

Inhalation administration to laboratory animal / affected organ(s): Lungs / signs: fibrosis
Dietary administration to Rat / signs: decreased growth rate
Intratracheal administration to Rat / affected organ(s): Lungs / signs: inflammation / (Dust inhalation)
Human experience
Inhalation:
Lungs: A benign dust induced lung condition, without impairment of lung function.. (dust) (repeated or
prolonged exposure) (severity of effects depends on extent of exposure)
Data for Silica (7631-86-9)
Acute toxicity
Oral:
Dermal:
Practically nontoxic. (rabbit) LD50 > 5,000 mg/kg.
Inhalation:
No deaths occurred. (rat) 4 h LC0 >= 2.08 mg/l. (dust/mist)
Skin Irritation:
Not irritating. (rabbit) Irritation Index: 0/8. (4 h)
Eye Irritation:
Not irritating. (rabbit) OECD Test Guideline 405

Repeated inhalation administration to rat / affected organ(s): lung, lymph node / signs: inflammation /
No adverse systemic effects reported. (Local effects, reversible)
Repeated dietary administration to rat / No adverse systemic effects reported.
Carcinogenicity
Chronic dietary administration to rat and mouse / affected organ(s): lung / No increase in tumor
incidence was reported.
in humans.
Genotoxicity
No genetic changes were observed in laboratory tests using: bacteria, animal cells, human cells, yeast
Genotoxicity
Assessment in Vivo:
No genetic changes were observed in a laboratory test using: rats
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Exposure during pregnancy. oral (rat, rabbit, hamster, mouse) / No birth defects were observed.
Reproductive effects
Reproduction Test. oral (rat) / No toxicity to reproduction.
Other information
Information given is based on data obtained from similar substances.
Human experience
Inhalation:
Respiratory system: No increase in tumor incidence was reported. No significant impairment of lung function.
(based on reports of occupational exposure to workers)
Data for Zeolites (1318-02-1)
Acute toxicity
Oral:
Practically nontoxic. (Rat) LD0 > 5,110 mg/kg.
Dermal:
No deaths occurred. (Rabbit) LD0 > 2,000 mg/kg.
Inhalation:
No deaths occurred. (Rat) 4 h LC0 > 3.35 mg/l.
Skin Irritation:
Not irritating. (Rabbit)
Eye Irritation:
Causes mild eye irritation. (Rabbit)
Skin Sensitization:
Not a sensitizer. Guinea pig maximization test. (Guinea pig) No skin allergy was observed

Subchronic dietary administration to rat, dog / affected organ(s): urinary bladder, kidney
Repeated inhalation administration to rat and monkey / affected organ(s): respiratory tract / signs: Local
irritation, irritation, inflammation, pneumonia
Carcinogenicity
Chronic oral administration to Rat / No increase in tumor incidence was reported.
in humans.
Genotoxicity
No genetic changes were observed in laboratory tests using: bacteria
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Both positive and negative responses for genetic changes were observed in laboratory tests using:
animal cells, human cells
Genotoxicity
Assessment in Vivo:
No genetic changes were observed in laboratory tests using: rats, mice
Exposure during pregnancy. oral (rat, rabbit) / No birth defects were observed.
Data for Sodium Oxide, Potassium Oxide (Proprietary)
Acute toxicity
Skin Irritation:
Causes severe skin burns. (Alkaline product.)
Eye Irritation:
Causes serious eye damage. (Alkaline product.)
Other information
Reacts with moisture.
Human experience
Inhalation:
Upper respiratory tract: coughing, irritation, sore throat, clinical chemistry changes, breathing difficulties,
accumulation of fluid in the lungs.
Human experience
Skin contact:
Skin: Dermatitis, itching, severe irritation, burning of skin. (extent of injury depends on severity of exposure)
Human experience
Eye contact:
Eyes: Pain, causes severe burns.
Human experience
Ingestion:
Gastro-intestinal tract: Pain, damage, perforation, shock.
Data for Crystalline silica - various forms (14464-46-1)

Repeated inhalation administration to rat, hamster, monkey / affected organ(s): Lungs / signs: fibrosis,
silicosis
Repeated inhalation administration to mouse / affected organ(s): Lungs, Immune system / signs:
fibrosis, immune suppression

Causes damage to organs through prolonged or repeated exposure.
Carcinogenicity
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Chronic Inhalation administration to rat / signs: Increase in tumor incidence was reported.
Classified by the International Agency for Research on Cancer as: Group 1: Carcinogenic to humans. Listed by
the National Toxicology Program as: Known human carcinogen.
Genotoxicity
Both positive and negative responses for genetic changes were observed in laboratory tests using:
animal cells, human cells
Genotoxicity
Assessment in Vivo:
Both positive and negative responses for genetic changes were observed in laboratory tests using: rats
Human experience
Inhalation:
Lung: silicosis, tumors, shortness of breath, wheezing, coughing, impaired lung function. (based on reports of
occupational exposure to workers)
Kidney: changes in organ structure or function. (based on reports of occupational exposure to workers)
Immune system: activation. (based on reports of occupational exposure to workers)
12. ECOLOGICAL INFORMATION
Chemical Fate and Pathway

No data are available.
Octanol Water Partition Coefficient:

log Pow: = 0.53(Method: calculated)
Ecotoxicology
Data for Aluminum oxide (Al2O3) (1344-28-1)
Aquatic toxicity data:

No effect up to the limit of solubility. Salmo trutta 96 h LL50 > 100 mg/l (Water accommodated fraction was
tested.)
Aquatic invertebrates:
No effect up to the limit of solubility. Daphnia magna (Water flea) 48 h EL50 > 100 mg/l (Water accommodated
fraction was tested.)
Algae:
No effect up to the limit of solubility. Selenastrum capricornutum 72 h EL50 > 100 mg/l (Water accommodated
fraction was tested.)
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Data for Calcium oxide (CaO) (1305-78-8)

Practically nontoxic. Cyprinus carpio (Carp) 96 h LC50 = 1,070 mg/l
Data for Bentonite (1302-78-9)

Practically nontoxic. Oncorhynchus mykiss (rainbow trout) 96 h LC50 = 19,000 mg/l
Data for Sepiolite (Mg4(OH)2(Si2O5)3.6H2O) (63800-37-3)

Practically nontoxic. Carassius auratus (goldfish) 96 h LC50 > 14,000 mg/l
Practically nontoxic. Salmo gairdneri 96 h LC50 = 1,254.44 mg/l
Algae:
Practically nontoxic. Algae IC50 > 300 mg/l
Data for Kaolin (1332-58-7)

Practically nontoxic. Shiner perch (Cymatogaster aggregate) 200 h LC50 = 3,000 mg/l

No effect up to the limit of solubility. Danio rerio (zebra fish) 96 h LC0 > 10,000 mg/l (nominal concentrations
reported)
No effect up to the limit of solubility. Daphnia magna (Water flea) 24 h LC0 > 10,000 mg/l (nominal
concentrations reported)
Algae:
No effect up to the limit of solubility. Desmodesmus subspicatus (green algae) 72 h EC0 > 10,000 mg/l (nominal
Data for Zeolites (1318-02-1)

No effect up to the limit of solubility. Pimephales promelas (fathead minnow) 96 h LC0 >= 680 mg/l (nominal
No effect up to the limit of solubility. Daphnia magna (Water flea) 48 h EC50 > 100 mg/l (Nominal concentration,
Water accommodated fraction was tested.)
Algae:
No effect up to the limit of solubility. Desmodesmus subspicatus (green algae) 72 h NOEC = 18 mg/l (Nominal
concentration, Water accommodated fraction was tested.)
Chronic toxicity to fish:
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
No effect up to the limit of solubility. Pimephales promelas (fathead minnow) 30 d NOEC > 86 mg/l
Chronic toxicity to aquatic invertebrates:

No effect up to the limit of solubility. Daphnia magna (Water flea) 21 d NOEC = 32 mg/l (Nominal concentration)
13. DISPOSAL CONSIDERATIONS
Waste disposal:
Disposal via incineration is recommended. Dispose of in accordance with federal, state and local regulations.
Consult a regulatory specialist to determine appropriate state or local reporting requirements, for assistance in
waste characterization and/or hazardous waste disposal and other requirements listed in pertinent environmental
permits. Note: Chemical additions to, processing of, or otherwise altering this material may make this waste
management information incomplete, inaccurate, or otherwise inappropriate. Furthermore, state and local waste
disposal requirements may be more restrictive or otherwise different from federal laws and regulations.
14. TRANSPORT INFORMATION
US Department of Transportation (DOT): not regulated
International Maritime Dangerous Goods Code (IMDG): not regulated
15. REGULATORY INFORMATION
Chemical Inventory Status
US. Toxic Substances Control Act TSCA This product complies with TSCA
requirements. For chemical identity
purposes, TSCA considers Zeolites as
crystalline aluminosilicates consisting of a
mixture of calcium oxide (CAS#1305-78-
8) and aluminum oxide (CAS# 1344-28-1)
in various proportions with metallic
oxides.
Canadian Domestic Substances List (DSL) DSL All components of this product are on the
Canadian DSL
China. Inventory of Existing Chemical Substances in IECSC (CN) Conforms to

China (IECSC)
Japan. ENCS - Existing and New Chemical ENCS (JP) Does not conform
Substances Inventory
Japan. ISHL - Inventory of Chemical Substances ISHL (JP) Does not conform
Korea. Korean Existing Chemicals Inventory (KECI) KECI (KR) Conforms to
Philippines Inventory of Chemicals and Chemical PICCS (PH) Conforms to

Substances (PICCS)
Australia Inventory of Chemical Substances (AICS) AICS Conforms to
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
United States – Federal Regulations
SARA Title III – Section 302 Extremely Hazardous Chemicals:

The components in this product are either not SARA Section 302 regulated or regulated but present in negligible
concentrations.
SARA Title III - Section 311/312 Hazard Categories:

Chronic Health Hazard
SARA Title III – Section 313 Toxic Chemicals:

The following components are subject to reporting levels established by SARA Title III, Section 313:
Chemical name CAS-No. De minimis Reportable threshold:

concentration
Aluminum oxide (Al2O3) 1344-28-1 1.0 % 25000 lbs (Manufacturing
and processing)
10000 lbs (Otherwise
used (non-
manufacturing/processing))
Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) - Reportable

Quantity (RQ):
The components in this product are either not CERCLA regulated, regulated but present in negligible
concentrations, or regulated with no assigned reportable quantity.
United States – State Regulations
New Jersey Right to Know
Chemical name CAS-No.

Aluminum oxide (Al2O3) 1344-28-1
Potassium oxide (K2O) 12136-45-7
Calcium oxide (CaO) 1305-78-8
Kaolin 1332-58-7
Silica 7631-86-9
Quartz (SiO2) 14808-60-7
New Jersey Right to Know – Special Health Hazard Substance(s)

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Quartz (SiO2) 14808-60-7
Pennsylvania Right to Know

Sodium oxide (Na2O) 1313-59-3
Bentonite 1302-78-9
Sepiolite (Mg4(OH)2(Si2O5)3.6H2O) 63800-37-3
Magnesium aluminium silicate 12174-11-7
Kaolin 1332-58-7
Silica 7631-86-9
Quartz (SiO2) 14808-60-7
Pennsylvania Right to Know – Environmentally Hazardous Substance(s)
California Prop. 65
WARNING! This product contains a chemical known to the State of California to cause cancer.

Quartz (SiO2) 14808-60-7
Cristobalite (SiO2) 14464-46-1
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
Magnesium aluminium silicate 12174-11-7
Tridymite 15468-32-3
Titanium oxide (TiO2) 13463-67-7
Cristalline silica (fine fraction) <10 µm (Proprietary)
16. OTHER INFORMATION
Full text of H-Statements referred to under sections 2 and 3.

H271 May cause fire or explosion; strong oxidizer.
H314 Causes severe skin burns and eye damage.
H315 Causes skin irritation.
H318 Causes serious eye damage.
H335 May cause respiratory irritation.
H350 May cause cancer.
H372 Causes damage to organs through prolonged or repeated exposure.
H373 May cause damage to organs through prolonged or repeated exposure.
Miscellaneous:
Other information: This SDS covers the following grades:

SILIPORITE BEADS: AIRSIEV OX19B, AIRSIEV OX8B, AIRSIEV
P140, EHP, EPX3 B, G5B, G5CBMLZ B, G5L 86 B, NK10B,
NK10CL, NK20C B, NK20C PLUS B, NK30 COS B, NK30B, OPX B,
OPXK B, OPXR B, PHYG3B, S82B, SRA B, SCR33, SCR53,
OPTISIEVE 4, NITROXY 5.
SILIPORITE EXTRUDATE/PELLETS: ANESIEV, CRYOSIEV P,
G5P, NK10 P, NK30 COS P, OPX P, OPXK P, OPXR P, PHYG1P,
RA, SRA P, NPG-50 P1.6, NK20C P1.6.
Latest Revision(s):
Reference number: 600001856

Date of Revision: 03/27/2018
Date Printed: 03/28/2018
SILIPORITE® is a registered trademark of Arkema Inc.
The statements, technical information and recommendations contained herein are believed to be accurate as of the date hereof.
Since the conditions and methods of use of the product and of the information referred to herein are beyond our control, ARKEMA
expressly disclaims any and all liability as to any results obtained or arising from any use of the product or reliance on such
information; NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY
OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE GOODS DESCRIBED OR THE INFORMATION
PROVIDED HEREIN. The information provided herein relates only to the specific product designated and may not be applicable
when such product is used in combination with other materials or in any process. The user should thoroughly test any application
before commercialization. Nothing contained herein constitutes a license to practice under any patent and it should not be
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

SAFETY DATA SHEET
SILIPORITE®
construed as an inducement to infringe any patent and the user is advised to take appropriate steps to be sure that any proposed
use of the product will not result in patent infringement. See SDS for Health & Safety Considerations.
Arkema has implemented a Medical Policy regarding the use of Arkema products in Medical Devices applications that are in contact
with the body or circulating bodily fluids (http://www.arkema.com/en/social-responsibility/responsible-product-management/medical-
device-policy/index.html) Arkema has designated Medical grades to be used for such Medical Device applications. Products that
have not been designated as Medical grades are not authorized by Arkema for use in Medical Device applications that are in
contact with the body or circulating bodily fluids. In addition, Arkema strictly prohibits the use of any Arkema products in Medical
Device applications that are implanted in the body or in contact with bodily fluids or tissues for greater than 30 days. The Arkema
trademarks and the Arkema name shall not be used in conjunction with customers' medical devices, including without limitation,
permanent or temporary implantable devices , and customers shall not represent to anyone else, that Arkema allows, endorses or
permits the use of Arkema products in such medical devices.
It is the sole responsibility of the manufacturer of the medical device to determine the suitability (including biocompatibility) of all raw
materials, products and components, including any medical grade Arkema products, in order to ensure that the final end-use
product is safe for its end use; performs or functions as intended; and complies with all applicable legal and regulatory requirements
(FDA or other national drug agencies) It is the sole responsibility of the manufacturer of the medical device to conduct all necessary
tests and inspections and to evaluate the medical device under actual end-use requirements and to adequately advise and warn
purchasers, users, and/or learned intermediaries (such as physicians) of pertinent risks and fulfill any postmarket surveillance
obligations. Any decision regarding the appropriateness of a particular Arkema material in a particular medical device should be
based on the judgment of the manufacturer, seller, the competent authority, and the treating physician.
Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

Arkema Mole Sieve - MSDS - July 2018

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Arkema Mole Sieve - MSDS - July 2018

Uploaded by

Copyright:

Available Formats

SAFETY DATA SHEET

1. PRODUCT AND COMPANY IDENTIFICATION

Customer Service Telephone Number: 1-800-248-2322

Transportation: CHEMTREC: (800) 424-9300

Product name: SILIPORITE®

*Classification of the substance or mixture:

Product code: 43000 Version 2.10 Issued on: 03/27/2018 Page: 1 / 23

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

Signal word: Danger

Supplemental Hazard Statements:

Potential Health Effects:

Medical conditions aggravated by overexposure:

Product code: 43000 Version 2.10 Issued on: 03/27/2018 Page: 2 / 23

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

Respiratory disease or diminished respiratory capacity.

Chemical Name CAS-No. Wt/Wt GHS Classification**

Aluminum oxide (Al2O3) 1344-28-1 >= 10 - < 30 % Not classified

Potassium oxide (K2O) 12136-45-7 >= 10 - < 30 % H314, H318

Sodium oxide (Na2O) 1313-59-3 >= 10 - < 30 % H271, H314, H318

Calcium oxide (CaO) 1305-78-8 >= 10 - < 30 % H315, H318, H335

Magnesium aluminium silicate 12174-11-7 >= 5 - < 10 % Not classified

Bentonite 1302-78-9 >= 5 - < 10 % Not classified

Sepiolite (Mg4(OH)2(Si2O5)3.6H2O) 63800-37-3 >= 5 - < 10 % H373

Kaolin 1332-58-7 >= 5 - < 10 % Not classified

Silica 7631-86-9 >= 1 - < 5 % Not classified

Product code: 43000 Version 2.10 Issued on: 03/27/2018 Page: 3 / 23

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

Quartz (SiO2) 14808-60-7 >= 1 - < 5 % H350, H372

Cristobalite (SiO2) 14464-46-1 >= 0.1 - <= 1 % H350, H372

4. FIRST AID MEASURES

4.1. Description of necessary first-aid measures:

4.2. Most important symptoms/effects, acute and delayed:

Extinguishing media (suitable):

Further firefighting advice:

Product code: 43000 Version 2.10 Issued on: 03/27/2018 Page: 4 / 23

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

This material is not flammable.

Fire and explosion hazards:

6. ACCIDENTAL RELEASE MEASURES

Personal precautions, Emergency procedures, Methods and materials for containment/clean-up:

7. HANDLING AND STORAGE

General information on handling:

General information on storage conditions:

Storage incompatibility – General:

Product code: 43000 Version 2.10 Issued on: 03/27/2018 Page: 5 / 23

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Airborne Exposure Guidelines:

Aluminum oxide (Al2O3) (1344-28-1)

US. ACGIH Threshold Limit Values

Form: Respirable fraction.

Form: Respirable fraction.

Form: Total dust

Calcium oxide (CaO) (1305-78-8)

US. ACGIH Threshold Limit Values

Time weighted average 2 mg/m3

US. ACGIH Threshold Limit Values

Form: Respirable fraction.

Form: Respirable fraction.

Form: Total dust

Product code: 43000 Version 2.10 Issued on: 03/27/2018 Page: 6 / 23

Quick-FDS [18350-47358-09144-013962] - 2018-03-28 - 13:09:19

US. OSHA Table Z-3 (29 CFR 1910.1000)